BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 19447324)

  • 1. Racial differences in women who have a hysterectomy for benign conditions.
    Weiss G; Noorhasan D; Schott LL; Powell L; Randolph JF; Johnston JM
    Womens Health Issues; 2009; 19(3):202-10. PubMed ID: 19447324
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of characteristics of fibroids in African American and white women undergoing premenopausal hysterectomy.
    Moorman PG; Leppert P; Myers ER; Wang F
    Fertil Steril; 2013 Mar; 99(3):768-776.e1. PubMed ID: 23199610
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Uterine leiomyomas. Racial differences in severity, symptoms and age at diagnosis.
    Kjerulff KH; Langenberg P; Seidman JD; Stolley PD; Guzinski GM
    J Reprod Med; 1996 Jul; 41(7):483-90. PubMed ID: 8829060
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Leiomyomas in an African Caribbean hysterectomy population considered to be ethnically related to African Americans.
    Kadhel P; Borja de Mozota D; Simon P; Toto T; Jermidi C; Ayhan G
    J Gynecol Obstet Hum Reprod; 2020 Feb; 49(2):101654. PubMed ID: 31760183
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of race, age and body mass index with gross pathology of uterine fibroids.
    Moore AB; Flake GP; Swartz CD; Heartwell G; Cousins D; Haseman JK; Kissling GE; Sidawy MK; Dixon D
    J Reprod Med; 2008 Feb; 53(2):90-6. PubMed ID: 18357799
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The health disparities of uterine fibroid tumors for African American women: a public health issue.
    Eltoukhi HM; Modi MN; Weston M; Armstrong AY; Stewart EA
    Am J Obstet Gynecol; 2014 Mar; 210(3):194-9. PubMed ID: 23942040
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Socioeconomic and racial predictors of undergoing laparoscopic hysterectomy for selected benign diseases: analysis of 341487 hysterectomies.
    Abenhaim HA; Azziz R; Hu J; Bartolucci A; Tulandi T
    J Minim Invasive Gynecol; 2008; 15(1):11-5. PubMed ID: 18262137
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Age-specific incidence rates for self-reported uterine leiomyomata in the Black Women's Health Study.
    Wise LA; Palmer JR; Stewart EA; Rosenberg L
    Obstet Gynecol; 2005 Mar; 105(3):563-8. PubMed ID: 15738025
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Racial and ethnic disparities in benign gynecologic conditions and associated surgeries.
    Jacoby VL; Fujimoto VY; Giudice LC; Kuppermann M; Washington AE
    Am J Obstet Gynecol; 2010 Jun; 202(6):514-21. PubMed ID: 20430357
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Social determinants of access to minimally invasive hysterectomy: reevaluating the relationship between race and route of hysterectomy for benign disease.
    Price JT; Zimmerman LD; Koelper NC; Sammel MD; Lee S; Butts SF
    Am J Obstet Gynecol; 2017 Nov; 217(5):572.e1-572.e10. PubMed ID: 28784416
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association Between Patient Characteristics and Treatment Procedure Among Patients With Uterine Leiomyomas.
    Borah BJ; Laughlin-Tommaso SK; Myers ER; Yao X; Stewart EA
    Obstet Gynecol; 2016 Jan; 127(1):67-77. PubMed ID: 26646122
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Black Women Are More Likely Than White Women to Schedule a Uterine-Sparing Treatment for Leiomyomas.
    Wegienka G; Stewart EA; Nicholson WK; Zhang S; Li F; Thomas L; Spies JB; Venable S; Laughlin-Tommaso S; Diamond MP; Anchan RM; Maxwell GL; Marsh EE; Myers ER; Vines AI; Wise LA; Wallace K; Jacoby VL
    J Womens Health (Larchmt); 2021 Mar; 30(3):355-366. PubMed ID: 33524308
    [No Abstract]   [Full Text] [Related]  

  • 13. The management of uterine leiomyomas.
    Lefebvre G; Vilos G; Allaire C; Jeffrey J; Arneja J; Birch C; Fortier M; Wagner MS;
    J Obstet Gynaecol Can; 2003 May; 25(5):396-418; quiz 419-22. PubMed ID: 12738981
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of Patient Race With Surgical Practice and Perioperative Morbidity After Myomectomy.
    Stentz NC; Cooney LG; Sammel MD; Shah DK
    Obstet Gynecol; 2018 Aug; 132(2):291-297. PubMed ID: 29995738
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence, characteristics, and risk factors of occult uterine cancer in presumed benign hysterectomy.
    Desai VB; Wright JD; Gross CP; Lin H; Boscoe FP; Hutchison LM; Schwartz PE; Xu X
    Am J Obstet Gynecol; 2019 Jul; 221(1):39.e1-39.e14. PubMed ID: 30853364
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The management of uterine leiomyomas.
    Vilos GA; Allaire C; Laberge PY; Leyland N;
    J Obstet Gynaecol Can; 2015 Feb; 37(2):157-178. PubMed ID: 25767949
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationship between hysterectomy and admixture in African American women.
    Qi L; Nassir R; Kosoy R; Garcia L; Waetjen LE; Ochs-Balcom HM; Gass M; Robbins J; Seldin MF
    Am J Obstet Gynecol; 2013 Apr; 208(4):279.e1-7. PubMed ID: 23333549
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Racial/Ethnic Disparities/Differences in Hysterectomy Route in Women Likely Eligible for Minimally Invasive Surgery.
    Pollack LM; Olsen MA; Gehlert SJ; Chang SH; Lowder JL
    J Minim Invasive Gynecol; 2020; 27(5):1167-1177.e2. PubMed ID: 31518712
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A possible role of the cytochrome P450c17alpha gene (CYP17) polymorphism in the pathobiology of uterine leiomyomas from black South African women: a pilot study.
    Amant F; Dorfling CM; de Brabanter J; Vandewalle J; Vergote I; Lindeque BG; van Rensburg EJ
    Acta Obstet Gynecol Scand; 2004 Mar; 83(3):234-9. PubMed ID: 14995917
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic Factors for Morcellation During Vaginal Hysterectomy.
    Wasson M; Butler K; Magtibay P; Temkit M; Magrina J
    Obstet Gynecol; 2016 Apr; 127(4):752-757. PubMed ID: 26959209
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.